SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028052
Filing Date
2021-05-14
Accepted
2021-05-14 16:59:21
Documents
64
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tern-10q_20210331.htm   iXBRL 10-Q 1882016
2 EX-31.1 tern-ex311_9.htm EX-31.1 19569
3 EX-31.2 tern-ex312_8.htm EX-31.2 19572
4 EX-32.1 tern-ex321_7.htm EX-32.1 9674
5 EX-32.2 tern-ex322_6.htm EX-32.2 9681
  Complete submission text file 0001564590-21-028052.txt   8230640

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tern-20210331.xsd EX-101.SCH 56618
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tern-20210331_cal.xml EX-101.CAL 48649
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tern-20210331_def.xml EX-101.DEF 189299
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tern-20210331_lab.xml EX-101.LAB 436346
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tern-20210331_pre.xml EX-101.PRE 343004
11 EXTRACTED XBRL INSTANCE DOCUMENT tern-10q_20210331_htm.xml XML 1710477
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39926 | Film No.: 21925679
SIC: 2834 Pharmaceutical Preparations